CTN 004: Clindamycin-primaquine, TMP-SMX for PCP

Read More

CTNPT 004: Effects of HLA allele frequencies on HIV disease progression

Read More

CTN 003: Multi-centre AZT trial

Read More

CTNPT 003: Bone and renal outcomes in tenofovir exposed infants

Read More

CTN 002: ddI, continued AZT

Read More

CTNPT 002: SPOT Impact of counselling on sexual risk behaviours

Read More

CTNPT 001: Fracture case-control study in HIV

Read More

Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine

Read More